Enterotoxigenic Escherichia Coli Infection
📧 Sign up to get email alerts when something new happens for Enterotoxigenic Escherichia Coli Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Efficacy Study of IM Administered CssBA+dmLT Against Moderate-severe Diarrhea in Human Infection Model With ETEC Strain B7A in Healthy Adults [Phase 2]
A Phase 2 efficacy study evaluating intramuscular CssBA+dmLT against moderate-to-severe diarrhea in healthy adults infected with enterotoxig…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122 [Phase 1]
Phase 1 study of the Shigella-ETEC vaccine strain CVD 1208S-122 (CVD 31000) completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Phase I Study of ETEC Vaccine [Phase 1]
A Phase I clinical trial of a vaccine targeting enterotoxigenic Escherichia coli (ETEC) has completed, evaluating safety and immunogenicity …
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: A Phase 2 Bridging Study to Assess the New Formulation of ETVAX [Phase 2]
A Phase 2 bridging study evaluating a new formulation of the ETVAX vaccine has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Pre-Study of Wild Type Enterotoxigenic E. Coli (ETEC) Strain for Verification of a Planned Challenge Dose [NA]
This clinical trial update reports a completed pre-study evaluating a wild-type Enterotoxigenic Escherichia coli strain to verify a planned …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-04-23Clinical Trial Update: Study Confirming A Human Challenge Model and Investigating The Safety Of VLA1701 [Phase 2]
Phase 2 clinical trial update on the safety of VLA1701 in an established human challenge model for Enterotoxigenic Escherichia coli infectio…
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Safety of Sublingual dmLT for ETEC [Phase 1]
This Phase 1 trial update provides safety data on sublingual dmLT for enterotoxigenic Escherichia coli (ETEC)–related gastroenteritis; the s…
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Challenge Study of an ETEC Vaccine [Phase 2]
Phase 2 trial of an Enterotoxigenic Escherichia coli vaccine sponsored by the U.S. Army MRDC has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-27Clinical Trial Update: Safety Study of Recombinant Vaccine to Prevent ETEC Diarrhea [Phase 1]
Phase 1 safety study of a recombinant vaccine intended to prevent diarrhea caused by Enterotoxigenic Escherichia coli (ETEC) has completed.
-
CLINICAL_TRIALS trial_result · 2011-03-07Clinical Trial Update: Safety and Efficacy Study of a Vaccine Against Enterotoxigenic Escherichia Coli (ETEC) to Prevent Moderate to Severe Diarrhea [Phase 2]
A Phase 2 clinical trial assessing the safety and efficacy of a vaccine against enterotoxigenic Escherichia coli to prevent moderate to seve…
-
CLINICAL_TRIALS trial_result · 2010-01-29Clinical Trial Update: ACE527 Safety and Immunogenicity Study [Phase 1]
Phase 1 safety and immunogenicity study of the ACE527 vaccine for Enterotoxigenic Escherichia coli infection has completed, reporting initia…